Skip to content
akaturk Academic measurement

Article detail · 2020

Frequency and Predictors of Major Bleeding in Patients With Embolic Strokes of Undetermined Source

Journal

Stroke

ISSN 0039-2499

YÖKSİS OpenAlex Open access · bronze SJR Q1 JCR Q1 Citations 9 Percentile 81.6% FWCI 1.25
Year
2020
Type
article

Data source split

  • YÖKSİS YÖKSİS article record
  • YÖKSİS venue Stroke
  • Catalog match (ISSN) Stroke
  • OpenAlex OpenAlex enrichment (abstract, citations, topics)

Abstract

OpenAlex · English

Background and Purpose: Risks, sites, and predictors of major bleeding during antithrombotic therapies have not been well defined for patients with recent embolic stroke of undetermined source. Methods: Exploratory analysis of major bleeds defined by International Society of Thrombosis and Hemostasis criteria occurring among 7213 participants in international NAVIGATE (New Approach Rivaroxaban Inhibition of Factor Xa in a Global Trial) embolic stroke of undetermined source randomized trial comparing rivaroxaban 15 mg daily with aspirin 100 mg daily. Results: During a median follow-up of 11 months, 85 major bleeds occurred. The most frequent site was gastrointestinal (38%), followed by intracranial (29%). Assignment to rivaroxaban (hazard ratio [HR], 2.7 [95% CI, 1.7–4.3]), East Asia region (HR, 2.5 [95% CI, 1.6–3.9]), systolic blood pressure ≥160 mm Hg (HR, 2.2 [95% CI, 1.2–3.8]), and reduced estimated glomerular filtration rate (HR, 1.2 per 10 mL/min per 1.73 m 2 decrease, [95% CI, 1.0–1.3]) were independently associated with presence of major bleeds. Five (6%) were fatal. Among 15 patients with intracerebral hemorrhage, 2 (13%) were fatal. There was no evidence of an early high-risk period following initiation of rivaroxaban. The annualized rate of intracerebral hemorrhage was 6-fold higher among East Asian participants (0.67%) versus all other regions (0.11%; HR, 6.3 [95% CI, 2.2–18.0]). Distribution of bleeding sites was similar for rivaroxaban and aspirin. Conclusions: Among embolic stroke of undetermined source patients participating in an international randomized trial, independent predictors of major bleeding were assignment to rivaroxaban, East Asia region, increased systolic blood pressure, and impaired renal function. East Asia as a region was strongly associated with risk of intracerebral hemorrhage. Estimated glomerular filtration rate should be a consideration for stratifying bleeding risk. Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT02313909.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

9 citations

OpenAlex cited_by_count (cache / database)

Authors

  1. R Mikulik
  2. Eckstein J
  3. Pearce LA
  4. H Mundl
  5. Rudilosso S
  6. Olavarría VV
  7. Shoamanesh A
  8. Chamorro A
  9. R Veltkamp
  10. ŞEREFNUR ÖZTÜRK SELÇUK ÜNİVERSİTESİ
  11. T Tatlisumak
  12. WF Peacock
  13. Bereczki D
  14. Connolly SJ
  15. Hart RG